At a glance
ClinicalIndex Comparison RecordN/ACompleted· 213 enrolled
Drug / intervention
hyaluronic acid geldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation
In Brief
A clinical study evaluating hyaluronic acid gel for Lip Augmentation. Completed, enrolled 213 participants across 1 site.
Detailed Summary
The purpose of this study is to demonstrate the safety and effectiveness of Juvederm(R) Ultra XC Injectable Gel for lip augmentation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Augmentation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedSep 2010
Primary CompletionJun 2014
Study CompletionJun 2015
TodayJul 2026
First PostedSep 9, 2010
Enrollment StartAug 1, 2010
Primary CompletionJun 19, 2014
Study CompletionJun 15, 2015
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 15.8 years ago
Interventions
hyaluronic acid geldevice
Dosage per Investigator's discretion to obtain lip treatment gel; 1 touch-up treatment is allowed 14 to 30 days after initial treatment. Repeat treatment occurs at month 12. Subjects in the control group start with treatment at month 3. Maximum total volume per subject is 4.8 mL for initial and touch-up treatment combined.